Atorvastatin Reduces Incidence of Heart Attacks, Strokes, in Patients with Diabetes

OCTOBER 01, 2004
Susan Farley

The cholesterol-lowering drug atorvastatin (Lipitor) offers significant benefits guarding against heart attacks and strokes among patients with diabetes. The Collaborative Atorvastatin Diabetes Study (CARDS) is the largest study of statin use in patients with diabetes, involving more than 2800 patients with type 2 diabetes, no history of heart disease, and relatively low levels of cholesterol.

Among those patients taking atorvastatin, there was a 37% reduction in major cardiovascular events, and 48% fewer patients taking atorvastatin experienced strokes, compared with those taking placebo. In fact, atorvastatin proved so effective that the study was stopped 2 years early. This was the second time a study of atorvastatin was stopped early because of significant cardiovascular benefits. The number of cases of type 2 diabetes is increasing at an epidemic level, which researchers attribute to genetics, obesity, and lack of exercise.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.